Skip to content

Clinical trials

Phase 3 Bipolar Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20043
20052
20062
20092
20121
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Charite University, Berlin, Germany1
Dr. Inge Winter1
Janssen Pharmaceutica N.V., Belgium1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Sumitomo Pharma America, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder13
Mania2
Depressive Disorder1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.